Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Sotorasib dosing and incremental cost ineffectiveness - implications and lessons for stakeholders.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sotorasib dosing and incremental cost ineffectiveness - implications and lessons for stakeholders.
Sotorasib dosing and incremental cost ineffectiveness - implications and lessons for stakeholders. Nat Rev Clin Oncol. 2024 Jan 30.
View in:
PubMed
authors with profiles
Mark J. Ratain